Overexpression of VEGF and/or it's receptor VEGFR2 contributes to invasiveness and metastasis of breast, lung, prostate, renal-cell, colon cancers and hepatocellular carcinoma [11,12]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.